Clinical Trials Browser

Phase 3 × Immune System Diseases × Other hematologic neoplasm × Clear all

Graft vs Host Disease, Immune System Diseases, Leukemia, Myelodysplastic Syndromes

NCT01650805 2014-11-17

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

T-Cell Depletion in Unrelated Donor Marrow Transplantation

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)